By Carlo Martuscelli

 

EKF Diagnostics Holdings PLC (EKF.LN) said that earnings in the first half of the year were marginally ahead of management's expectations, and that it has signed a distribution agreement for the U.S.

The healthcare company said that the agreement is with an affiliate of McKesson Corp. (MCK) and is for its DiaSpect hemoglobin analyzer.

EKF said that the slight beat to expectations came despite currency headwinds. Net cash at June 30 was 9 million pounds ($11.6 million), compared with GBP4 million at the same time last year.

 

Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com

 

(END) Dow Jones Newswires

August 09, 2018 03:59 ET (07:59 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
McKesson (NYSE:MCK)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more McKesson Charts.
McKesson (NYSE:MCK)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more McKesson Charts.